| [1] 吴玉斌.过敏性紫癜性肾炎的治疗进展[J].中国实用儿科学杂志，2006,21(6):411-413.[2] Hamdan JM, Barqawi MA. Henoch-Schonlein purpura in children.Influence of age on the incidence of nephritis and arthritis.Saudi Med J.2008;29(4):549-552.[3] Gabriella M, Beniamina G, Alessandro D, et al. Renal transplantation in adults with Henoch-Schönlein purpura: long-term outcome. Neph Dia Trans.2008;23(9): 3010-3016.[4] Heli F,Hemmi H,Hochrein H,et al.Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8.Science.2004;303(5663):1526-1529．[5] 陶于洪,罗秋红.Toll 样受体与肾脏疾病研究进展[J].实用儿科杂志, 2012, 27(17):1362-1365.[6] 中华医学会儿科学分会肾脏病学组.儿童常见肾脏疾病诊治循证指南(二):紫癜性肾炎的诊治循证指南(试行)[J].中华儿科杂志, 2009,47(12):911-913.[7] Ozen S, Ruperto N, Dillon M J, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis.2006;65(7):936–941.[8] Kenneth J.Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^-ΔΔCT Method, Methods.2001;25:402-408.[9] Davin JC, Weening JJ. Henoch-Schonlein purpura nephritis:an update. Eur J Pediatr.2001;160(12):689-695.[10] Rostoker G.Schonlein-henoch purpura in children and adults:diagnosis, pathophysiology and management.Bio Drugs.2001;15(2): 99-138.[11] Takeda K,Kaisho T,Akira S.Toll-like receptors.Annu Rev Immunol, 2003;21:335-376．[12] 金丹,吕凤林.TLR3免疫识别dsRNA病毒的分子机制[J].病毒学报,2005,21(2):156-159.[13] Ohnishi T, Muroi M, Tansmoto K. N- linked glycosylations at Asn(26) and Asnl(114) of human MD-2 are required for toll-like receptor 4-mediated activation of NF-kappaB by lipopolysaccharide.J Immunol.2001;167(6):3354-3359.[14] Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16:3-9.[15] Tanaka T, Legat A, Adam E, et al. DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4. Eur J Immunol.2008;38(5):1351-1357.[16] Akira S, Takeda K, Kaisho T.Toll-like receptors: critical proteins linking innate and acquired immunity.Nat Immunol. 2001;2(8):675-680.[17] Gluba A,Banach M,Hannam S,et al. The role of Toll-like receptors in renal diseases.Nat Rev Nephrol.2010;6( 4) : 224-235.[18] Hawn TR.scholes D.wang H,et al.Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women.PLoS One.2009; 4(12):e8300-e8311.[19] Cunningham PN,Wang Y,Guo R,et al.Role of Toll—like receptor 4 in endotoxin-induced acute renal failure.J Immunol.2004;172(4):2629-2635.[20] Rusai K.Sollinger D,Baumann M,et al.Toll—like receptor 2 and 4 in renal ischemia/reperfusion injury.Pediatr Nephrol. 2010;25(5):853-860.[21] Lai Y,Yi G,Chen A,et al.Viral double-strand RNA-binding proteins can enhance innate immune signaling by Toll-like Receptor 3.PLoS One.2011;6(10):e25837-e25849.[22] Coppo R,camilla R,Amore A, et al. Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy.Clim Exp Immunol.2010;159(1):73-81.[23] Giorgni A,Brown HJ,Sacks SH, et al.Toll—like receptor 4 stimulation triggers crescentic glomerulonephritis by multiple mechanisms including a direct effect on renal cells.Am J Pathol.2010;177(2):644-653.[24] Sedor JR, Nakazato Y,Konjezkowski M. Interleukin- 1 and the mesangial cell. Kidney Int.1992;41:595-599.[25] Gallicchio M,McFarlan e J,Hufnagl P,et al.Stimulation of PAI-l in rabbit anti-GBM glomerulonephritis. Nephrology.1998;4: 65-74.[26] Watts RA,Scott DG.Epidemiology of vasculities.Curr Opin Rheumatol. 2003;15(1):11-16.[27] 唐玉英,朱保权,付生军,等.过敏性紫癜患儿外周血树突状细胞IL-6、IL-12的分泌及CD80、CD86的表达[J]. 临床儿科杂志, 2009,27(1):58-60. |
